Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2001, p. 1417-1421, Vol. 45, No. 5
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1417-1421.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Activities of Bismuth Thiols against Staphylococci
and Staphylococcal Biofilms
Philip
Domenico,1,*
Lucilla
Baldassarri,2
Paul E.
Schoch,1
Kristina
Kaehler,3
Masanori
Sasatsu,4 and
Burke A.
Cunha1
Winthrop-University Hospital, Mineola, and State University
of New York School of Medicine, Stony Brook, New
York1; Istituto Superiore de
Sanitá, Rome, Italy2; SurModics
Inc., Eden Prairie, Minnesota3; and
Tokyo University of Pharmacy and Life Sciences, Tokyo,
Japan4
Received 29 September 2000/Returned for modification 30 November
2000/Accepted 13 February 2001
 |
ABSTRACT |
Indwelling medical devices are associated with infectious
complications. Incorporating antimicrobials into indwelling materials may reduce bacterial colonization. Bismuth thiols are antibiofilm agents with up to 1,000-fold-greater antibacterial activity than other
bismuth salts. Staphylococci are particularly sensitive, as determined
by agar diffusion and broth dilution susceptibility testing.
Bismuth-ethanedithiol inhibited 10 methicillin-resistant Staphylococcus epidermidis strains at 0.9 to 1.8, Staphylococcus aureus ATCC 25923 at 2.4, and S. epidermidis ATCC 12228 at 0.1 µM Bi3+.
Antiseptic-resistant S. aureus was sensitive to
bismuth-2-3-dimercaptopropanol (BisBAL) at
7 µM Bi3+.
Hydrogel-coated polyurethane rods soaked in BisBAL inhibited S. epidermidis for 39 days (inhibitory zone diameter in agar,
30
mm for >25 days). Slime from 16 slime-producing S. epidermidis strains was inhibited significantly by
bismuth-3,4-dimercaptotoluene (BisTOL), but not by AgNO3,
at subinhibitory concentrations. In conclusion, bismuth-thiols are
bacteriostatic and bactericidal against staphylococci, including
resistant organisms, but are also inhibitors of slime at subinhibitory
concentrations. At subinhibitory concentrations, BisTOL may be useful
in preventing the colonization and infection of indwelling
intravascular lines, since staphylococci are important pathogens in
this setting.
 |
INTRODUCTION |
Staphylococci are ubiquitous skin
microflora and important nosocomial and community-acquired pathogens.
Coagulase-negative staphylococci are the most common cause of
foreign-body device infection and have become increasingly prevalent in
nosocomial bacteremia and infections in the immunocompromised host
(10, 11, 15). Staphylococcus aureus is
frequently implicated in wound infections, osteomyelitis, endocarditis,
and sepsis (20, 24). Multiresistant strains
(methicillin-resistant S. aureus [MRSA] and
methicillin-resistant Staphylococcus epidermidis [MRSE]) commonly colonize the skin and nares of hospitalized patients and
personnel, serving as a reservoir for nosocomial infection and
antibiotic resistance genes transferable to staphylococci and other
bacteria (3, 12, 21). Staphylococci can adhere to a
variety of foreign materials. Once established, such infections are
difficult to resolve. The emergence of resistant staphylococci has
raised concern that effective antimicrobial regimens may not be
available in the near future (23).
Bismuth thiols (BTs) are a group of novel biocides with potent,
broad-spectrum activity (8). BTs inhibit bacteria at up to
1,000-fold-lower concentrations than other bismuth salts. At subinhibitory concentrations, BTs suppress bacterial exopolysaccharide expression in Klebsiella and Pseudomonas spp.,
which prevents biofilm formation and renders the bacteria susceptible
to host defenses (9). At concentrations from 0.6 to 1 ppm
(3 to 5 µM Bi3+), bismuth-2-3-dimercaptopropanol (BisBAL)
suppressed capsule and slime production by 70 to 90%, with only
marginal effects on growth (9). Exopolysaccharides are
also important virulence factors for staphylococci (18,
22).
One approach to preventing infection due to indwelling devices is the
bonding of antimicrobial agents to catheter material. Silver-impregnated devices have proven efficacy, as have other antiseptics (14, 17). BTs may prove superior in this
regard. The possible advantages of BTs over other metal-based
antiseptics and antifouling agents (e.g., silver, copper, and
organotins) include safety, since bismuth is relatively nontoxic
compared to other heavy metals. BTs also inhibit slime expression and
are particularly effective at inhibiting and killing staphylococci (17, 24). This report documents the potent antibacterial
and antibiofilm activities of BTs against various staphylococci,
including resistant strains.
 |
MATERIALS AND METHODS |
Bacteria and culture conditions.
The bacteria employed
include clinical isolates of S. aureus, MRSA and MRSE, the
reference strains S. aureus ATCC 25923 and S. epidermidis ATCC 12228, and the antiseptic-resistant S. aureus strains FDA209P, L20A, N20, MEK23, and MEK24. Strains L20A
and N20 show resistance to ethidium bromide, quaternary ammonium
compounds, and glutaraldehyde (19). S. epidermidis RP62A (ATCC 35984), a slime-producing strain, was
employed in coated-rod agar diffusion studies, as well as in slime
production studies. Other bacteria employed include Escherichia
coli ATCC 25922, Enterococcus faecalis ATCC 29212, and
clinical isolates of vancomycin-resistant enterococci, E. coli,
Legionella pneumophila, Burkholderia cepacia, and
Pseudomonas aeruginosa. Slime assay organisms included
S. epidermidis RP62A and 15 slime-producing S. epidermidis clinical isolates grown in Trypticase soy broth (TSB)
with 1% glucose (4). The bacteria were subcultured weekly
on Mueller-Hinton agar supplemented with 1% Fildes enrichment (Difco
Laboratories, Detroit, Mich.), also used for agar diffusion studies.
Broth dilution was performed in Mueller-Hinton II broth. The broth was
supplemented with 1% Fildes enrichment and 20 mM NaCl.
BT preparation.
The agents employed were
bismuth-1,2-ethanedithiol (BisEDT), BisBAL, bismuth-2-mercaptoethanol
(Bis
ME), bismuth-3,4-dimercaptotoluene (BisTOL), and
bismuth-pyrithione (BisPYR) (6). Liquid and powder forms
were prepared at various molar ratios. The proposed structures of some
of these compounds have been published (1). BT solutions were prepared in propylene glycol using bismuth nitrate and
commercially prepared thiols (Sigma-Aldrich Corporation, St. Louis,
Mo.). Five micromolar BTs is approximately equal to 1 µg of
bismuth/ml.
Susceptibility studies.
Staphylococci were tested for
susceptibility in agar and broth media. In agar diffusion studies,
plates were streaked with 106 bacteria. Sterile paper disks
(6-mm diameter) were placed on the surface and impregnated with 5 µl
of agent in propylene glycol. Inhibitory-zone diameters were measured
at 24 h. Broth dilution studies were performed in accordance with
NCCLS standards. The bacteria were tested for susceptibility to several
BT agents at a wide range of concentrations (0.1 to 100 µM bismuth; 5 µM = 1 µg/ml). The MIC is expressed as the concentration of BT
inhibiting visual growth for 24 ± 2 h. Minimum bactericidal
concentrations (MBC) are expressed as the BT concentration that reduced
viability by 99.9%, as determined by plating the bacteria on agar medium.
Catheter studies.
Uncoated polyurethane catheter material
(3-mm diameter) was treated with SurModics PhotoLink technology, a
polyvinylpyrrolidone-based hydrogel. Catheters were soaked overnight at
25°C in 50/75 mM BisBAL (pH 12.5), rinsed in sterile distilled
H2O for 5 s to remove excess BisBAL, and embedded in
Mueller-Hinton agar with a lawn of S. epidermidis RP62A or
E. coli ATCC 25922 at 106 CFU/ml. The plates
were incubated overnight at 37°C, and the zone diameter perpendicular
to the rod in which no growth was apparent was measured. The rods were
transferred daily to fresh lawns on Mueller-Hinton agar. The diameter
of the zone of inhibition (in millimeters) is expressed as the mean
from three samples. The diameter of the rod was 3 mm, which was
equivalent to no zone.
Slime assay.
A quantitative adherence assay was employed to
test for slime production (4). Briefly, 1:100 dilutions of
overnight cultures in TSB were used to inoculate wells in a microtiter
polystyrene plate. After growth for 24 or 48 h at 37°C, the
plates were gently washed three times with phosphate-buffered saline,
and the adherent bacteria were fixed at 60°C for 1 h and then
stained with Hucker's crystal violet; excess stain was washed off with
tap water. The optical density (OD) of the biofilm was measured at 570 nm in a spectrophotometer (Novapath Microplate Reader; BioRad
Laboratories Inc.). To examine the effect of BT compounds or silver
nitrate (2) on slime production, BTs were prepared as
described above and diluted directly into culture medium. S. epidermidis growth was followed by determining the OD of cultures
at 600 nm (OD600) and by counting CFU on blood agar media.
The results were analyzed to evaluate the possible effect of growth
rate and cell density on slime formation. Accordingly, the slime index
was defined as an estimate of the density of the biofilm generated by a
culture with an OD600 of 0.5 [slime index = mean OD
of the biofilm × (0.5/mean OD growth)] (7).
Statistics.
Where possible, data are presented as the mean
of at least three independent trials along with the standard deviation.
Differences in slime production were analyzed by the Wilcoxon test for
related rankable scores.
 |
RESULTS |
The susceptibility of MRSA to BTs was examined by agar diffusion.
Forty-seven MRSA strains were tested with BisBAL and compared to other
pathogenic bacteria (Table 1). BisBAL
produced an average inhibition zone diameter of 18.7 mm against MRSA,
compared to the relative absence of inhibition produced by the
individual components that make up BisBAL. Isolates of other bacteria,
though sensitive to one degree or another, were less sensitive than
S. aureus.
The susceptibilities of S. aureus to various BTs in broth
dilution studies are summarized in Table
2. BTs were prepared in propylene glycol
at 5 and 2.5 mM. BisTOL was superior to the other compounds with regard
to MBC. BisEDT was the most inhibitory but was not an effective
bactericidal agent, as was BisTOL, BisPYR, or BisBAL. Propylene glycol
alone at 1% in culture medium had no inhibitory effect.
Several BTs, formulated as either liquids or powders at various molar
ratios, were tested against a variety of staphylococci (Table
3). BisBAL 3:1 powder inhibited 87 S. aureus strains on average below 15 µM compared to
BisPYR 2:1 powder, which inhibited an MRSA strain at 2.5 µM. Among
the liquid preparations, BisEDT was most active, inhibiting 10 MRSE
strains at an average of 1.1 µM Bi3+, S. epidermidis ATCC 12228 at 0.09 µM Bi3+, and S. aureus ATCC 25923 at 2.4 µM Bi3+. Bis
ME at 1:1.4
inhibited 65 S. aureus clinical isolates at an average of
23.7 µM Bi3+.
BTs were also tested against antiseptic-resistant S. aureus.
The antiseptic-resistant strains L20A and N20 were actually more sensitive to BisBAL (MICs,
1 µM Bi3+) than the
antiseptic-sensitive strain FDA209P (MIC, 6 µM Bi3+)
Moreover, the triclosan- and mupirocin-resistant strains MEK23 (MIC, 7 µM Bi3+) and MEK24 (MIC, 6 µM Bi3+) were as
sensitive to BisBAL as was the antiseptic-sensitive strain. All strains
were susceptible to BisBAL at or below 7 µM (1.4 µg of
Bi3+/ml).
BTs were also tested for long-term slow release from catheter-related
materials. Hydrogel-coated polyurethane rods saturated with BisBAL were
tested daily in agar diffusion studies. The diameters of zones BT
inhibition around hydrogel-coated and uncoated rods for a
slime-forming S. epidermidis strain were measured and are summarized in Fig. 1. Hydrogel-coated
rods exhibited strong antibacterial activity for over 1 month. Against
E. coli, zones were produced for 19 days (Fig. 1). Rods
without hydrogel coating showed no inhibition of bacteria after day 1.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Inhibitory action of BisBAL-coated polyurethane rods.
Hydrogel-coated rods were soaked in 50 or 75 mM BisBAL overnight and
embedded int agar plates seeded with S. epidermidis ( ) or
E. coli ( ). Rods without BisBAL were also tested against
S. epidermidis ( ) and E. coli ( ). The
plates were incubated overnight at 37°C, and the zones of inhibition
were measured. The rods were transferred daily to fresh plates. Zone
diameters are expressed as the means of three samples. The diameter of
the rod was 3 mm, which was equivalent to no zone.
|
|
To analyze glycocalyx formation, S. epidermidis strain RP62A
was treated with several BT compounds at subinhibitory concentrations. Slime production was affected at sub-MICs of BisTOL, BisBAL, BisPYR, and BisEDT (data not shown). However, only sub-MIC BisTOL strongly limited slime production under these conditions. Figure
2 shows 24- and 48-h slime inhibition at
1.25 µM BisTOL, though culture growth was apparent
(OD600 = 0.30; 5 × 108 CFU/ml).
Higher BisTOL levels were more growth inhibitory. The slime-inhibiting
effect of BisTOL was verified by examining its effect at 24 h on
15 additional slime-producing S. epidermidis clinical
isolates (Table 4). Biofilm ODs were
significantly lower (P < 0.002) after growth in 1.25 µM BisTOL, with an average reduction in slime of 86.4% ± 0.07% and
a range from 68.1 to 96.0%. All BisTOL-treated bacteria exhibited
growth at 24 h.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of BisTOL on growth (solid bars) and on biofilm
formation (stippled bars) by S. epidermidis RP62A after 24 (A) and 48 (B) h. Bacteria adhering to microtiter plates were stained
and measured for absorbence as described in Materials and Methods. The
values are means of triplicate determinations (± standard
deviations).
|
|
Silver nitrate inhibited the growth rate and slime production of
S. epidermidis (MIC, 94 µg/ml), but no effect on slime
expression was seen at subinhibitory concentrations (Table
5). Thus, for AgNO3, the
slime index from RP62A samples showing growth ranged from 1.29 to 2.20 (Table 5), while that for sub-MIC BisTOL ranged from 0.05 to 0.133 among the 15 strains tested (Table 4). The slime index for the
untreated control was 1.22.
 |
DISCUSSION |
Infection due to multiple antibiotic-resistant staphylococci is a
growing problem. Emerging resistance to several agents, including
macrolides, quinolones, ethidium bromide, antiseptics, disinfectants,
and heavy metals (3, 5, 19), is of major concern.
Moreover, the production of slime by S. epidermidis is associated with the clinical features of infection and enables bacteria
to colonize catheters (16). Slime (biofilm) provides an
ecological niche that attracts nutrients and protects against antimicrobial agents and cellular immunity (6). As a
result, successful therapy of many staphylococcal infections has proven difficult to attain.
In this regard, BTs may be of benefit. Slow release of BisBAL
from hydrogel-coated polyurethane rods retarded the growth of slime-forming S. epidermidis for 39 days, producing an
average zone of inhibition diameter of 27.8 mm. The 1:1.5 molar ratio of bismuth to BAL was significant, since other ratios and
concentrations were not as active (data not shown), nor was a catheter
which was not coated with hydrogel. This molar ratio produced a neutral BT compound, thereby increasing the hydrophobicity and facilitating a
linkage to the plastic surface. Medical devices that use polyurethane include central venous and hemodialysis catheters, pacemaker leads, guidewires, synthetic vascular grafts, heart valves, cardiac assist devices, artificial organs, breast implants, and wound dressings, to
name a few. The duration of BT release from polyurethane devices in a
liquid medium would probably have been more reflective of the in vivo
situation than the agar medium used, which constitutes a potential
drawback to these catheter studies.
Equally promising is the effect of BTs on staphylococcal glycocalyx.
BTs suppress staphylococcal exopolysaccharides at subinhibitory concentrations. BisTOL was superior to the other BTs tested, preventing slime formation on polystyrene microtiter plates at 1.25 µM (0.25 µg/ml) after 24- and 48-h incubations. It is not known why BisTOL was
more active than other BTs. BisTOL is the only aromatic BT tested,
which may conceivably boost activity against gram-positive bacteria.
The antibiofilm properties of BisTOL also compare favorably to those of
silver (Table 6). BisTOL inhibited biofilms at 0.25 µg/ml versus 94 µg of silver/ml. The effect of silver also appeared to be on growth
rather than on biofilm formation, whereas BisTOL suppressed biofilm
even in the presence of growth (Table 4).
For comparison, Klebsiella pneumoniae capsule expression was
inhibited by BisBAL or BisEDT at
1 µg/ml (9).
Glycocalyx inhibition by BTs thus appears to be broad spectrum in that
it affects both gram-positive and gram-negative bacteria. Glycocalyx inhibition is achievable in defined or complex media, though some medium effects have been documented. The selection of BT may be important, depending on the bacteria involved.
At higher concentrations, BTs inhibited all staphylococci tested,
including resistant strains. Staphylococci resistant to various
antiseptics and antibiotics were tested for sensitivity to BTs. None
were resistant to BTs, including methicillin-resistant strains.
Bacteria resistant to mupirocin, triclosan, and quaternary ammonium
compounds were sensitive to BTs. Thus no cross-resistance was noted.
BTs readily gain entry into bacteria, due to their cationic
detergentlike structure, and interfere with redox enzymes (8,
13). Exopolysaccharide expression is energy intensive and is
inhibited early on, due to a rapid drop in intracellular ATP levels
(unpublished data).
Several BTs were strongly bactericidal. The MBC against S. aureus was, on average, twofold greater than the MIC. BisEDT was not appreciably bactericidal, though it was quite effective at inhibiting growth. Generally speaking, BTs were more active against the
staphylococci than against streptococci or gram-negative bacteria (Table 1) (8).
The unique bacteriostatic, bactericidal, and antibiofilm properties of
BTs may be useful to prevent or treat staphylococcal infections.
Against staphylococci, BTs are potent agents, show no cross-resistance,
are released slowly from implants for long-term antisepsis, and retard
slime expression at safe concentrations. Their broad-spectrum effects
may render BTs useful as anti-infectives and preservatives against
bacteria in a variety of settings.
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Winthrop-University Hospital, 259 First St., Mineola, NY 11501. Phone:
(516) 663-2654. Fax: (516) 663-3886. E-mail:
domenico{at}winthrop.org.
 |
REFERENCES |
| 1.
|
Agocs, L.,
G. G. Briand,
N. Burford,
T. S. Cameron,
W. Kwiatkowski, and K. N. Robertson.
1997.
The structurally flexible bicyclic bis(2-hydroxyethanethiolato)bismuth(III) complex: a model for asymmetric monoanionic chelation of bismuth(III).
Inorg. Chem.
36:2855-2860[CrossRef][Medline].
|
| 2.
|
Akiyama, H.,
O. Yamasaki,
H. Kanzaki,
J. Tada, and J. Arata.
1998.
Effects of sucrose and silver on Staphylococcus aureus biofilms.
J. Antimicrob. Chemother.
42:629-634[Abstract/Free Full Text].
|
| 3.
|
Archer, G. L., and M. W. Climo.
1994.
Antimicrobial susceptibility of coagulase-negative staphylococci.
Antimicrob. Agents Chemother.
38:2231-2237[Free Full Text].
|
| 4.
|
Baldassarri, L.,
W. A. Simpson,
G. Donelli, and G. D. Christensen.
1993.
Variable fixation of staphylococcal slime by different histochemical fixatives.
Eur. J. Clin. Microbiol. Infect. Dis.
12:866-868[CrossRef][Medline].
|
| 5.
|
Boyce, J. M.
1989.
Methicillin-resistant Staphylococcus aureus: detection, epidemiology, and control measures.
Infect. Dis. Clin. N. Am.
3:901-913[Medline].
|
| 6.
|
Costerton, J. W.,
K. J. Cheng,
G. G. Geesey,
T. I. Ladd,
J. C. Nickel, and M. Dasgupta.
1987.
Bacterial biofilms in nature and disease.
Annu. Rev. Microbiol.
41:435-464[CrossRef][Medline].
|
| 7.
|
Deighton, M., and R. Borland.
1993.
Regulation of slime production in Staphylococcus epidermidis by iron limitation.
Infect. Immun.
61:4473-4479[Abstract/Free Full Text].
|
| 8.
|
Domenico, P.,
R. J. Salo,
S. G. Novick,
P. E. Schoch,
K. Van Horn, and B. A. Cunha.
1997.
Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.
Antimicrob. Agents Chemother.
41:1697-1703[Abstract].
|
| 9.
|
Domenico, P.,
J. M. Tomas,
S. Merino,
X. Rubires, and B. A. Cunha.
1999.
Surface antigen exposure by bismuth-thiol suppression of Klebsiella pneumoniae capsular polysaccharide.
Infect. Immun.
67:664-669[Abstract/Free Full Text].
|
| 10.
|
Eykyn, S. J.
1984.
Infection and intravenous catheters.
J. Antimicrob. Chemother.
14:23-25.
|
| 11.
|
Haslett, T. M.,
H. D. Isenberg,
E. Hilton,
V. Tucci,
B. G. Kay, and E. M. Vellozzi.
1988.
Microbiology of indwelling central intravascular catheters.
J. Clin. Microbiol.
26:696-701[Abstract/Free Full Text].
|
| 12.
|
Kluytmans, J.,
A. Belkum, and H. Verbrugh.
1997.
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.
Clin. Microbiol. Rev.
10:505-520[Abstract].
|
| 13.
|
Mahony, D. E.,
S. Lim-Morrison, and L. Bryden.
1999.
Antimicrobial activities of synthetic bismuth compounds against Clostridium difficile.
Antimicrob. Agents Chemother.
43:582-588[Abstract/Free Full Text].
|
| 14.
|
Maki, D. G.,
S. M. Stolz,
S. Wheeler, and L. A. Mermel.
1997.
Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial.
Ann. Intern. Med.
127:257-266[Abstract/Free Full Text].
|
| 15.
|
Needham, C. A., and W. Stempsey.
1984.
Incidence, adherence and antibiotic resistance of coagulase-negative staphylococcus species causing human disease.
Diagn. Microbiol. Infect. Dis.
2:293-299[CrossRef][Medline].
|
| 16.
|
Peters, G.,
R. Locci, and G. Pulverer.
1982.
Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters.
J. Infect. Dis.
146:479-482[Medline].
|
| 17.
|
Raad, I.,
R. Darouiche,
R. Hachem,
M. Mansouri, and G. P. Bodey.
1996.
The broad spectrum activity and efficacy of catheters coated with minocycline and rifampicin.
J. Infect. Dis.
73:418-424.
|
| 18.
|
Rupp, M. E.,
J. S. Ulphani,
P. D. Fey, and D. Mack.
1999.
Characterization of the importance of polysaccharide intercellular adhesin/hemagglutination of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model.
Infect. Immun.
67:2627-2632[Abstract/Free Full Text].
|
| 19.
|
Sasatsu, M.,
Y. Shibata,
N. Noguchi, and M. Kono.
1992.
High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus.
FEMS Microbiol. Lett.
93:109-114[CrossRef].
|
| 20.
|
Sheagren, J. N.
1984.
Staphylococcus aureus: the persistent pathogen.
N. Engl. J. Med.
310:1368-1373[Medline], 1437-1442.
|
| 21.
|
Shuter, J.,
V. B. Hatcher, and F. D. Lowy.
1996.
Staphylococcus aureus binding to human nasal mucin.
Infect. Immun.
64:310-318[Abstract].
|
| 22.
|
Thakker, M.,
J.-S. Park,
V. Carey, and J. C. Lee.
1998.
Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.
Infect. Immun.
66:5183-5189[Abstract/Free Full Text].
|
| 23.
|
Tomasz, A.
1994.
Multiple-antibiotic resistant pathogenic bacteria: a report on the Rockefeller University Workshop.
N. Engl. J. Med.
330:1247-1251[Free Full Text].
|
| 24.
|
Waldvogel, F. A.
1995.
Staphylococcus aureus, p. 1754-1777.
In
G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practices of infectious diseases, 4th ed. Churchill Livingstone, New York, N.Y.
|
Antimicrobial Agents and Chemotherapy, May 2001, p. 1417-1421, Vol. 45, No. 5
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1417-1421.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Burton, E., Gawande, P. V., Yakandawala, N., LoVetri, K., Zhanel, G. G., Romeo, T., Friesen, A. D., Madhyastha, S.
(2006). Antibiofilm Activity of GlmU Enzyme Inhibitors against Catheter-Associated Uropathogens.. Antimicrob. Agents Chemother.
50: 1835-1840
[Abstract]
[Full Text]
-
Kotani, T., Nagai, D., Asahi, K., Suzuki, H., Yamao, F., Kataoka, N., Yagura, T.
(2005). Antibacterial Properties of Some Cyclic Organobismuth(III) Compounds. Antimicrob. Agents Chemother.
49: 2729-2734
[Abstract]
[Full Text]
-
Bland, M. V., Ismail, S., Heinemann, J. A., Keenan, J. I.
(2004). The Action of Bismuth against Helicobacter pylori Mimics but Is Not Caused by Intracellular Iron Deprivation. Antimicrob. Agents Chemother.
48: 1983-1988
[Abstract]
[Full Text]
-
Veloira, W. G., Domenico, P., LiPuma, J. J., Davis, J. M., Gurzenda, E., Kazzaz, J. A.
(2003). In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex. J Antimicrob Chemother
52: 915-919
[Abstract]
[Full Text]
-
Wu, C.-L., Domenico, P., Hassett, D. J., Beveridge, T. J., Hauser, A. R., Kazzaz, J. A.
(2002). Subinhibitory Bismuth-Thiols Reduce Virulence of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Bio.
26: 731-738
[Abstract]
[Full Text]